Cumulative adverse effect of diabetes mellitus and hypertension on coronary flow velocity reserve

Archives des Maladies du Coeur et des Vaisseaux

Volumn 97, Issue 9, 2004, Pages 849-854

  Le Feuvre, C ^a   Raoux, F ^a   Beygui, F ^a   Helft, G ^a   Mogenet, A ^b   Dubois Laforgue, D ^b   Timsit, J ^b   Metzger, J P ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Coronary disease; Diabetes mellitus; Hypertension; Microcirculation

Indexed keywords

ARTICLE; CARDIOMYOPATHY; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY BLOOD FLOW; DIABETES MELLITUS; ESSENTIAL HYPERTENSION; FEMALE; FLOW RATE; HIGH RISK PATIENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; TRANSLUMINAL CORONARY ANGIOPLASTY; ANGIOCARDIOGRAPHY; BLOOD FLOW VELOCITY; COMPARATIVE STUDY; CORONARY BLOOD VESSEL; ECHOGRAPHY; HEART RATE; MICROCIRCULATION; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY;

BLOOD FLOW VELOCITY; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY VESSELS; DIABETES MELLITUS, TYPE 2; FEMALE; HEART RATE; HUMANS; HYPERTENSION; MALE; MICROCIRCULATION; MIDDLE AGED; MULTIVARIATE ANALYSIS;

EID: 4644269616     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Sowers JR, Epstein M, Frohlich ED. Diabetes, hypertension, and cardiovascular disease: an update. Hypertension 2001; 37: 1053-9.
2. Yokoyama I, Momomura SI, Ohtake T et al. Reduced myocardial flow reserve in non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 1997; 30: 1472-7.
3. Nitemberg A, Valensi P, Sachs R, Dali M, Aptecar E, Attali JR. Impairment of coronary vascular reserve and ACh-induced coronary vasodilation in diabetic patients with angioraphically normal coronary arteries and normal left ventricular systolic function. Diabetes 1993; 42: 1017-25.
4. Nahser PJ, Brown RE, Oskarsson H, Winniford M, Rossen JD. Maximal coronary flow reserve and metabolic coronary vasodilatation in patients with diabetes mellitus. Circulation 1995; 91: 635-40.
5. Houghton JL, Frank MJ, Carr AA, von Dohlen TW, Prisant M. Relations among impaired coronary flow reserve, left ventricular hypertrophy and thallium perfusion defects in hypertensive patients without obstructive coronary artery disease. J Am Coll Cardiol 1990; 15: 43-51.
6. Rizzoni D, Porteri E, Guelfi D et al. Structural alterations in subcutaneous small arteries of normotensive and hypertensive patients with non-insulin-dependent diabetes mellitus. Circulation 2001; 103: 1238-44.
7. Arorra GD, Reeves WC, Movahed A. Alteration of coronary perfusion reserve in hypertensive patients with diabetes. J Hum Hypertens 1994; 8: 51-7.
8. Galderisi M, Caso P, Cicala S et al. Positive association between circulating free insulin-like growth factor-1 levels and coronary flow reserve in arterial systemic hypertension. Am J Hypertens 2002; 15: 766-72.
9. Takiuchi S, Rakugi H, Masuyama T et al. Hypertension attenuates the efficacy of hypoglycemic therapy for preserving coronary flow reserve in patients with type 2 diabetes. Hypertens Res 2002; 25: 893-900.
10. Schiller NB, Shah PM, Crawford M. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee an Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2: 358-67.
11. Ganau A, Devereux RB, Roman MJ et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992; 19: 1550-60.
12. Le Feuvre C, Baubion N, Aubry N, Metzger JP, de Vernejoul P, Vacheron A. Assessment of reversible dyssynergic segments after myocardial infarction: dobutamine echocardiography versus thallium-201 single photon emission computed tomography. Am Heart J 1996; 131: 668-75.
13. Lafont A, Dubois-Randé JL, Steg PG et al. The French Randomized Optimal Stenting Trial: a prospective evaluation of provisional stenting guided by coronary velocity reserve and quantitative coronary angiography. FROST study group. J Am Coll Cardiol 2000; 36: 404-9.
14. Mintz GS, Painter JA, Pichard AD. Atherosclerosis in angiographycally normal coronary artery reference segments: an intravascular ultrasound study with clinical correlations. J Am Coll Cardiol 1995; 25: 1479-85.
15. Giacomelli E, Wiener J. Primary myocardial disease in the diabetic mouse: an ultrastructural study. Lab Invest 1979; 40: 460-73.
16. Hamby RI, Zoneraich S, Sherman L. Diabetic cardiomyopathy. JAMA 1974; 229: 1749-54.
17. Hoffman JI. Maximal coronary flow and the concept of coronary vascular reserve. Circulation 1984; 70: 153-9.
18. Zimlichman R, Zaidel L, Nofech-Mozes S. Hyperinsulinemia induces myocardial infarctions and arteriolar medial hypertrophy in spontaneously hypertensive rats. Am J Hypertens 1997; 10: 646-53.
19. Factor SM, Minase T, Cho S. Coronary microvascular abnormalities in the hypertensive-diabetic rat. A primary cause of cardiomyopathy? Am J Pathol 1984; 116: 9-20.
20. Strauer BE, Motz W, Vogt M, Schwartzkopff B. Impaired coronary flow reserve in NIDDM: a possible role for diabetic cardiopathy in humans. Diabetes 1997; 46: 119-24.
21. Pitkanen OP, Nuutila P, Raitakari et al. Coronary flow reserve is reduced in young men with IDDM. Diabetes 1998; 47: 248-54.
22. McGinn AL, Wilson RF, Olivari MT, Homans DC, White CW. Coronary vasodilator reserve after human orthotopic cardiac transplantation. Circulation 1988; 78: 1200-9.
23. Lethen H, Tries HP, Brechtken J, Kersting S, Lambertz H. Comparison of transthoracic Doppler echocardiography to intracoronary Doppler guidewire measurements for assessment of coronary flow reserve in the left anterior descending artery for detection of restenosis after coronary angioplasty. Am J Cardiol 2003; 91: 412-7.
24. Treasure CB, Klein JL, Vita JA, Manoukian SV, Ganz P, Alexander RW. Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels. Circulation 1993; 87: 86-93.
25. Gould KL, Kirkeeide RL, Buchi M. Coronary flow reserve as a physiologic measure of stenotic severity. J Am Call Cardiol 1990; 15: 459-74.
26. Serruys PW, de Mario C, Kiek P. Prognostic value of intracoronary flow velocity and diameter stenosis in assessing the short-and long-term outcomes of coronary balloon angioplasty: the DEBATE Study (Doppler Endpoints Ballaon Angioplasty Trial Europe). Circulation 1997; 96: 3369-77.
27. Kern MJ. The meaning of suboptimal coronary flow reserve after coronary balloon angioplasty. Eur Heart J 2002; 23: 99-100.